Cargando…
PARP inhibitors: current status and implications for anticancer therapeutics
Poly(ADP-ribose) polymerases (PARPs) comprise of a large family of 17 proteins encoded by various genes which participate in genome maintenance, apoptosis, inflammatory responses and the regulation of gene expression programs. PARP inhibitors, as therapeutic agents, come into play acting on both PAR...
Autores principales: | Usmani, Hadi, Hussain, Syed Ather, Sheikh, Asfandyar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175919/ https://www.ncbi.nlm.nih.gov/pubmed/24289880 http://dx.doi.org/10.1186/1750-9378-8-46 |
Ejemplares similares
-
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
por: Bhutani, Jaikrit, et al.
Publicado: (2013) -
The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics
por: Sheikh, Asfandyar, et al.
Publicado: (2014) -
Hedgehog pathway inhibitors – current status and future prospects
por: Sheikh, Asfandyar, et al.
Publicado: (2012) -
PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015) -
c-Met inhibitors
por: Mughal, Anum, et al.
Publicado: (2013)